April 2026
The lung stent market size was exhibited at USD 235.84 million in 2025 and is expected to surpass around USD 690.33 million by 2035, with a solid CAGR of 11.34%.
June 2026
The global lung cancer surgery market size was evaluated at USD 1.55 billion in 2025 and is predicted to hit around USD 2.76 billion by 2035, growing at a CAGR of 5.95%.
February 2026
The global metastatic non-small cell lung cancer market size was evaluated at USD 18.50 billion in 2025 and is predicted to hit around USD 50.30 billion by 2035, growing at a CAGR of 10.52%.
February 2026
The global aortic stent grafts market size was evaluated at USD 4.10 billion in 2025 and is predicted to hit around USD 8.57 billion by 2035, growing at a CAGR of 7.65%.
February 2026
The global bioresorbable coronary stents market size was evaluated at USD 357.18 million in 2025 and is predicted to hit around USD 641.47 million by 2035, growing at a CAGR of 6.03%.
December 2025
The global small cell lung cancer therapeutics market size is projected to hit around USD 22.86 billion by 2035 from USD 7.25 billion in 2025 with a CAGR of 12.17%.
December 2025
The lung disease therapeutics market size was estimated at USD 96.82 billion in 2025 and is expected to hit over USD 173.48 billion by 2035 with a CAGR of 6.01%.
November 2025
The global lung cancer diagnostics market size is estimated at USD 5.35 billion in 2025 and is predicted to hit around USD 9.45 billion by 2034 with a CAGR of 6.53%.
November 2025
The global stents market size is calculated at USD 14.50 billion in 2025 and is projected to hit around USD 25.23 billion by 2034 with a CAGR of 6.35%.
November 2025
The coronary stents market size is projected to hit around USD 17.40 billion by 2034, increasing from USD 10.35 billion in 2025 at a CAGR of 6%.
August 2025
The global ureteral stents market size was estimated at USD 575.54 million in 2024 and is expected to attain around USD 1,128.19 million by 2034, with a CAGR of 6.96%.
June 2025
The global biliary stents market size is expected to worth around USD 25.70 billion by 2034 from USD 15.73 billion in 2024 with a CAGR of 5.03%.
February 2025
The lung cancer therapeutics market size is valued at USD 35.37 billion in 2025 and is expected to hit around USD 76.65 billion by 2035, growing at a CAGR of 8.04%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com